Investor volatility plagues drug companies on new Chinese exchange.Published in:Nature Biotechnology, 2010, v. 28, n. 1, p. 9, doi. 10.1038/nbt0110-9By:Mitchell, Peter;Fu Jing BeijingPublication type:Article